Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO

Core Insights - Schusterman Interests has initiated a new position in HeartFlow, Inc. by acquiring over 1.9 million shares valued at $65.3 million, making it the fund's fourth-largest holding [2][3][10] Company Overview - HeartFlow, Inc. specializes in advanced, non-invasive diagnostic tools for coronary artery disease, leveraging artificial intelligence and computational modeling to improve clinical decision-making and patient outcomes [6] - The company generates revenue primarily from its proprietary AI-powered HeartFlow Platform and related healthcare information services [6] Financial Metrics - As of the latest market close, HeartFlow shares are priced at $32.25, reflecting a 70% increase from the IPO price of $19 [4][11] - HeartFlow's market capitalization stands at $2.7 billion, with a total revenue of $161.9 million and a net income of -$125.4 million for the trailing twelve months [5] Investment Context - The acquisition by Schusterman Interests represents 14.9% of the fund's 13F reportable assets under management, indicating a significant allocation to HeartFlow [7][10] - The investment reflects confidence in HeartFlow's technology and its potential for durable revenue growth in a large, under-digitized market [9][11]